Postoperatively, HBsAg and HBsAb titers were measured every other day until the patient became HBsAg negative and HBsAb positive. After discharge from the hospital, patients were reviewed in the ...
Inside the hepatocytes, HBV produces a surplus of viral antigens, including hepatitis B e antigen (HBeAg) and hepatitis B s antigen (HBsAg), which is HBV’s envelope protein. In addition to the ...
In a new clinical practice guideline, the AGA provided evidence-based recommendations for either antiviral prophylaxis or continued surveillance to manage hepatitis B virus reactivation in patients ...
“Functional cure — defined as a sustained loss of HBsAg and undetectable HBV DNA at 24 weeks after finite-duration therapy — is a desired treatment outcome that is associated with ...
positive or negative, chronic hepatitis B patients who are currently on nucleos(t)ide antiviral therapy and have HBV DNA levels below 40IU/mL and HBsAg levels under 500IU/mL. Virion dosed the ...